Loading...
Prostate cancer immunotherapy, particularly in combination with androgen deprivation or radiation treatment. Customized pharmacogenomic approaches to overcome immunotherapy cancer resistance
Conventional therapeutic approaches for advanced prostate cancer - such as androgen deprivation, chemotherapy, radiation - come up often against lack of effectiveness because of possible arising of correlative cancer cell resistance and/or inadequate anti-tumor immune conditions. Whence the timeline...
Na minha lista:
| Udgivet i: | G Chir |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
CIC Edizioni Internazionali
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5256907/ https://ncbi.nlm.nih.gov/pubmed/28098061 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11138/gchir/2016.37.5.225 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|